Latest Regulatory Milestones News

BCI Minerals has marked a significant milestone with the commencement of full-scale operations at its Mardie Salt and Sulphate of Potash Project and secured initial drawdowns from a $981 million syndicated debt facility, underscoring strong progress toward first salt shipment by late 2026.

Invictus Energy has secured a three-year extension for its Cabora Bassa Basin licence and gained environmental approval for pilot gas production, setting the stage for expanded exploration and early commercialisation in Zimbabwe.

Lefroy Exploration has partnered with BML Ventures in a profit-sharing agreement to fast-track mining at the Lucky Strike Gold Project, backed by promising drilling results that validate and expand the resource base.

Piche Resources has extended its Cerro Chacon gold-silver mineralised corridor to 14km and identified multiple high-grade uranium zones at Sierra Cuadrada, setting the stage for an 8,000m drilling campaign in 2Q 2025.

Coda Minerals has expanded its Elizabeth Creek copper-cobalt-silver project with new drilling success at Emmie East, revealing mineralised shale beyond the main resource. Concurrent metallurgical testwork aims to boost recoveries and reduce capital costs.

Altamin Limited reports steady progress on its Lazio and Gorno projects, with positive testwork confirming the feasibility of sulphate of potash, lithium carbonate, and boron recovery from geothermal brines. The company moves closer to pre-feasibility studies and environmental approvals amid a tight cash position.

AKORA Resources has successfully renewed its main tenement PR10430 for the Bekisopa Iron Ore Project, marking a pivotal step under Madagascar’s updated Mining Code and reinforcing the project’s path to production.

Prospect Resources has declared a maiden JORC-compliant copper resource of 107.2 million tonnes at 0.5% copper at its Mumbezhi Project in Zambia, alongside securing a strategic A$15.2 million investment from First Quantum Minerals. This milestone advances the project towards development with Phase 2 drilling planned for Q2 2025.

Neurizon Therapeutics reported a sharp rise in half-year losses to $7.28 million but marked significant progress with its lead drug NUZ-001 entering a major ALS clinical trial and securing critical regulatory designations.

PYC Therapeutics has launched a A$145.8 million pro-rata accelerated non-renounceable entitlement offer to fund late-stage clinical trials across its pipeline targeting rare diseases with high unmet needs. The capital raise aims to extend the company’s cash runway beyond FY27, supporting four drug candidates through critical human safety and efficacy milestones.

Trigg Minerals has secured NSW Government approval for the transfer of its Achilles Project licence, enabling formal exploration of the high-grade Wild Cattle Creek antimony deposit.

Artrya Limited has launched a A$15 million capital raising to fund the development and commercial rollout of its Salix AI-powered coronary artery disease diagnostic platform, targeting the lucrative US healthcare market.